News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bay Area's IMPAX Laboratories, Inc. (IPXL) Get Subpoena In Price Fixing Probe


7/16/2014 7:35:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A generic heart drug made by Impax Laboratories Inc. and two other companies is at the center of an investigation by the Connecticut attorney general's office over a spike in price.

The inquiry, which revolves around the drug generically known as digoxin, is focused on two areas. Authorities will probe if the drug's price was fixed or if the company violated state antitrust laws by dividing customers or territories for digoxin sales, Hayward-based Impax (NASDAQ: IPXL) said Tuesday.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES